Censa is developing therapies for orphan metabolic diseases with earlier stage programs targeting central nervous system diseases

Biopterins are endogenous essential co-factors for aromatic amino acid hydroxylases enzymes

Defects in biopterin dependent biochemical pathways are associated with severe metabolic and neurologic pathologies

 

 

Developing Medicines to Improve the Lives of Patients with Debilitating Diseases

 

News & Media